AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27161620 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive antihypertensive therapy (systolic BP <120 mm Hg)
Number of subjects: 1672
Study 27161620 — intervention group
Group type: COMPARATOR
Intervention: Standard antihypertensive therapy (systolic BP <140 mm Hg)
Number of subjects: 1672
Study 25186799 — intervention group
Group type: EXPERIMENTAL
Intervention: IGIV 0.2g/kg
Number of subjects: 16
Study 25186799 — intervention group
Group type: EXPERIMENTAL
Intervention: IGIV 0.4g/kg
Number of subjects: 16
Study 25186799 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 22613901 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab (5 or 10 mg/kg)
Number of subjects: 2119
Study 22613901 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunomodulator treatment (vs. treatment without immunomodulator) in UC patients
Number of subjects: 2119
Study 22613901 — intervention group
Group type: COMPARATOR
Intervention: Immunomodulator use in placebo-treated CD patients
Number of subjects: 2119
Study 22613901 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab or immunomodulator treatment
Number of subjects: 2119
Study 20146676 — intervention group
Group type: EXPERIMENTAL
Intervention: 3‐4 component therapy plus SCUF or CVVHF
Number of subjects: 22
Study 20146676 — intervention group
Group type: COMPARATOR
Intervention: Intravenous furosemide
Number of subjects: 22
Study 18307128 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotherapy
Number of subjects: 44
Study 18307128 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study 15990772 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention program (avoidance of house dust, pets, environmental tobacco smoke, encouragement of breast-feeding, delayed introduction of solid foods)
Number of subjects: 545
Study 15990772 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention program
Number of subjects: 545
Study 15990772 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention details provided)
Number of subjects: 545
Study 12560434 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant oophorectomy and tamoxifen
Number of subjects: 282
Study 10582669 — intervention group
Group type: EXPERIMENTAL
Intervention: Permanent low dose-rate I-125 seeds placement after resection
Number of subjects: 15
Study 8727171 — intervention group
Group type: EXPERIMENTAL
Intervention: Besipirdine 5 mg b.i.d.
Number of subjects: 275
Study 8727171 — intervention group
Group type: EXPERIMENTAL
Intervention: Besipirdine 20 mg b.i.d.
Number of subjects: 275
Study 8727171 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 275
Study 8727171 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (combined besipirdine doses)
Number of subjects: 275
Study 8727171 — intervention group
Group type: EXPERIMENTAL
Intervention: Global ratings (Clinician Interview-Based Impression of Change)
Number of subjects: 275
Study 8727171 — intervention group
Group type: EXPERIMENTAL
Intervention: Besipirdine
Number of subjects: 275
Study 8727171 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-treatment assessment
Number of subjects: 275
Study 1744753 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program consisting of three sessions led by a specially trained RN, focusing on medication compliance, attack prevention, drug effects, relaxation exercises, and smoking cessation.
Number of subjects: 241
Study 1744753 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving usual medical care and follow-up without the educational program.
Number of subjects: 241
Study 1744753 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program
Number of subjects: 241
Study 7064898 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 kcal high quality protein
Number of subjects: 38
Study 7064898 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 kcal low quality protein
Number of subjects: 38
Study 7064898 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 kcal 55 g protein natural food
Number of subjects: 38
Study 7064898 — intervention group
Group type: COMPARATOR
Intervention: total fasting with potassium
Number of subjects: 38
Study 7064898 — intervention group
Group type: COMPARATOR
Intervention: total fasting without potassium
Number of subjects: 38
Study 31534032 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrogen dioxide (NO2)
Number of subjects: 423
Study 31534032 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrogen oxide (NO)
Number of subjects: 423
Study 31534032 — intervention group
Group type: COMPARATOR
Intervention: Normal airways
Number of subjects: 423
Study 27649903 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Group Therapy (CBGT)
Number of subjects: 137
Study 27649903 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness and Acceptance-based Group Therapy (MAGT)
Number of subjects: 137
Study 27649903 — intervention group
Group type: COMPARATOR
Intervention: Waitlist Control
Number of subjects: 137
Study 27064996 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily abacavir + lamivudine
Number of subjects: 669
Study 27064996 — intervention group
Group type: COMPARATOR
Intervention: Twice-daily abacavir + lamivudine
Number of subjects: 669
Study 24736370 — intervention group
Group type: EXPERIMENTAL
Intervention: ITNs + IRS (Indoor Residual Spraying)
Number of subjects: 13146
Study 24736370 — intervention group
Group type: COMPARATOR
Intervention: ITNs only
Number of subjects: 13146
Study 24736370 — intervention group
Group type: EXPERIMENTAL
Intervention: ITNs + IRS
Number of subjects: 13146
Study 22079053 — intervention group
Group type: EXPERIMENTAL
Intervention: Chiropractic spinal manipulative therapy (SMT)
Number of subjects: 18
Study 22079053 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 18
Study 20061012 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual allergens (nAct d 1‐5 and rAct d 8‐9)
Number of subjects: 45
Study 20061012 — intervention group
Group type: COMPARATOR
Intervention: Commercial extract
Number of subjects: 45
Study 20061012 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Act d 1, Act d 2, Act d 4, and Act d 5
Number of subjects: 45
Study 20061012 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusion of rAct d 8 and rAct d 9 from allergen panel
Number of subjects: 45
Study 20061012 — intervention group
Group type: EXPERIMENTAL
Intervention: Act d 1
Number of subjects: 45
Study 20061012 — intervention group
Group type: EXPERIMENTAL
Intervention: rAct d 8
Number of subjects: 45
Study 18005841 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine sulphate premedication (600 microg)
Number of subjects: 51
Study 18005841 — intervention group
Group type: COMPARATOR
Intervention: No premedication (control)
Number of subjects: 51
Study 16224378 — intervention group
Group type: EXPERIMENTAL
Intervention: Amelogenins and autologous bone graft
Number of subjects: 2
Study 16224378 — intervention group
Group type: COMPARATOR
Intervention: Open flap debridement
Number of subjects: 2
Study 11821078 — intervention group
Group type: EXPERIMENTAL
Intervention: r‐hFSH 50 IU
Number of subjects: 45
Study 11821078 — intervention group
Group type: EXPERIMENTAL
Intervention: r‐hFSH 100 IU
Number of subjects: 45
Study 11821078 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 45
Study 10025747 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream
Number of subjects: 69
Study 10025747 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study 1364129 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene (BC) supplementation
Number of subjects: 0
Study 3947525 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol nebulized at 4 litres/min (1 mg)
Number of subjects: 40
Study 3947525 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol nebulized at 8 litres/min (5 mg)
Number of subjects: 40
Study 30392753 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal Shock Wave Therapy (ESWT)
Number of subjects: 42
Study 30392753 — intervention group
Group type: COMPARATOR
Intervention: Botulinum Toxin Type A (BoNT‐A)
Number of subjects: 42
Study 27266885 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrust manipulation
Number of subjects: 27
Study 27266885 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint mobilization
Number of subjects: 27
Study 27266885 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 27
Study 25415250 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics (500 mg metronidazole plus 375 mg amoxicillin three times per day for 7 days) during the first, non‐surgical phase of periodontal therapy (T1)
Number of subjects: 80
Study 25415250 — intervention group
Group type: COMPARATOR
Intervention: Placebo during the first, non‐surgical phase of periodontal therapy (T1)
Number of subjects: 80
Study 25415250 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics during the second, surgical phase of periodontal therapy (T2)
Number of subjects: 80
Study 25415250 — intervention group
Group type: COMPARATOR
Intervention: Placebo during the second, surgical phase of periodontal therapy (T2)
Number of subjects: 80
Study 23498850 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole (400 mg tablet every 6 months)
Number of subjects: 2589
Study 23498850 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 2589
Study 21255511 — intervention group
Group type: EXPERIMENTAL
Intervention: O(2) Flow Regulator
Number of subjects: 18
Study 21255511 — intervention group
Group type: COMPARATOR
Intervention: Manual titration by respiratory therapist
Number of subjects: 18
Study 18245541 — intervention group
Group type: EXPERIMENTAL
Intervention: E75 vaccine (HER2/neu 369-377) + granulocyte macrophage colony-stimulating factor, given intradermally to previously treated, disease-free NP breast cancer patients.
Number of subjects: 186
Study 18245541 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-HLA-A2 and non-HLA-A3 patients) followed prospectively.
Number of subjects: 186
Study 16476069 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitogenic bovine whey extract (2.5 mg/mL)
Number of subjects: 0
Study 16476069 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitogenic bovine whey extract (10.0 mg/mL)
Number of subjects: 0
Study 16476069 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitogenic bovine whey extract (various concentrations)
Number of subjects: 0
Study 16476069 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 16736996 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinapril
Number of subjects: 20
Study 16736996 — intervention group
Group type: COMPARATOR
Intervention: Vitamin C
Number of subjects: 20
Study 10835071 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA-supplemented formula
Number of subjects: 9
Study 10835071 — intervention group
Group type: COMPARATOR
Intervention: DHA-free formula
Number of subjects: 9
Study 9792996 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastrin infusion at 5 pmol kg‐1 h
Number of subjects: 7
Study 9792996 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastrin infusion at 15 pmol kg‐1 h
Number of subjects: 7
Study 9792996 — intervention group
Group type: COMPARATOR
Intervention: Basal acid output
Number of subjects: 7
Study 9792996 — intervention group
Group type: COMPARATOR
Intervention: Low-dose gastrin stimulated acid output
Number of subjects: 7
Study 9792996 — intervention group
Group type: COMPARATOR
Intervention: High-dose gastrin stimulated acid output
Number of subjects: 7
Study 9792996 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma PP levels during gastrin‐17 infusion
Number of subjects: 7
Study 7931379 — intervention group
Group type: EXPERIMENTAL
Intervention: Lignocaine
Number of subjects: 100
Study 7931379 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 100
Study 7931379 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 100
Study 3144329 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 50 mg or 100 mg twice daily
Number of subjects: 39
Study 3144329 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil 120 mg or 240 mg twice daily
Number of subjects: 39
Study 3144329 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 39
Study 3144329 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol and Verapamil
Number of subjects: 39
Study 31210596 — intervention group
Group type: EXPERIMENTAL
Intervention: Text message-based educational intervention
Number of subjects: 135
Study 31210596 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 135
Study 30475967 — intervention group
Group type: EXPERIMENTAL
Intervention: Nut group (60 g of a mixture of nuts/d)
Number of subjects: 119
Study 30475967 — intervention group
Group type: COMPARATOR
Intervention: Control group (avoiding nuts)
Number of subjects: 119
Study 28112077 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary cholesterol (600 mg/d)
Number of subjects: 49
Study 28112077 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant sterols (2 g/d)
Number of subjects: 49
Study 28112077 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 49
Study 26072451 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple Context Exposure in VR
Number of subjects: 58
Study 26072451 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple Stimuli Condition
Number of subjects: 58
Study 26072451 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Multiple Stimuli and Contexts Condition
Number of subjects: 58
Study 26072451 — intervention group
Group type: EXPERIMENTAL
Intervention: Single Context with Multiple Stimuli
Number of subjects: 58
Study 22705829 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 32
Study 22705829 — intervention group
Group type: EXPERIMENTAL
Intervention: 30° inclined lateral position
Number of subjects: 32
Study 19748277 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-incisional lidocaine with epinephrine infiltration
Number of subjects: 18
Study 19748277 — intervention group
Group type: COMPARATOR
Intervention: Normal saline solution
Number of subjects: 18
Study 19469266 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 105
Study 19469266 — intervention group
Group type: COMPARATOR
Intervention: Non-smokers
Number of subjects: 105
Study 19469266 — intervention group
Group type: COMPARATOR
Intervention: Ex-smokers
Number of subjects: 105
Study 16780670 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimodipine for 3 months
Number of subjects: 31
Study 16780670 — intervention group
Group type: COMPARATOR
Intervention: Basic internal medication (Control)
Number of subjects: 31
Study 14560325 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-6 and sIL-6R serum levels in patients with AMI and unstable angina
Number of subjects: 74
Study 14560325 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-10 serum concentration
Number of subjects: 74
Study 14560325 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of IL-6 and sIL-6R with acute inflammatory phase parameters and classical risk factors
Number of subjects: 74
Study 10654017 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral metronidazole; 20 courses (18 empiric)
Number of subjects: 80
Study 10654017 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vancomycin; 10 courses (8 empiric)
Number of subjects: 80
Study 10654017 — intervention group
Group type: EXPERIMENTAL
Intervention: C. difficile toxin assay
Number of subjects: 80
Study 10654017 — intervention group
Group type: EXPERIMENTAL
Intervention: Diarrhea occurrence
Number of subjects: 80
Study 8774818 — intervention group
Group type: EXPERIMENTAL
Intervention: Rate adaptive pacing (SSIR)
Number of subjects: 20
Study 8774818 — intervention group
Group type: COMPARATOR
Intervention: Fixed rate pacing (SSI)
Number of subjects: 20
Study 1420042 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous intravenous propofol infusion
Number of subjects: 49
Study 1420042 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous intravenous midazolam infusion
Number of subjects: 49
Study 1420042 — intervention group
Group type: COMPARATOR
Intervention: No intravenous sedation
Number of subjects: 49
Study 2864258 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyzine 20 mg
Number of subjects: 24
Study 2864258 — intervention group
Group type: EXPERIMENTAL
Intervention: Clemastine 3 mg
Number of subjects: 24
Study 2864258 — intervention group
Group type: EXPERIMENTAL
Intervention: Azatadine 3 mg
Number of subjects: 24
Study 2864258 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound score (Hydroxyzine)
Number of subjects: 24
Study 2864258 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation analysis
Number of subjects: 24
Study 30880909 — intervention group
Group type: EXPERIMENTAL
Intervention: Seawater spray (Quinton®) five times daily
Number of subjects: 120
Study 30880909 — intervention group
Group type: COMPARATOR
Intervention: Carmellose artificial tears eyedrops (Viscofresh® 0.5%) five times a day
Number of subjects: 120
Study 28776123 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition educational intervention
Number of subjects: 92
Study 28776123 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 92
Study 27091536 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep Restriction (SR) group with 5 hours TIB during manipulation nights
Number of subjects: 55
Study 27091536 — intervention group
Group type: COMPARATOR
Intervention: Control group with 9 hours TIB during manipulation nights
Number of subjects: 55
Study 24496490 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation (TMS) over left or right temporoparietal junction (TPJ)
Number of subjects: 0
Study 24496490 — intervention group
Group type: COMPARATOR
Intervention: Control stimulation over the vertex
Number of subjects: 0
Study 22985805 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 80 mg once daily for a maximum of 28 days
Number of subjects: 540
Study 22985805 — intervention group
Group type: COMPARATOR
Intervention: Placebo once daily for a maximum of 28 days
Number of subjects: 540
Study 20195400 — intervention group
Group type: EXPERIMENTAL
Intervention: rosuvastatin 10 mg
Number of subjects: 351
Study 17368663 — intervention group
Group type: EXPERIMENTAL
Intervention: MenC vaccine
Number of subjects: 0
Study 17368663 — intervention group
Group type: EXPERIMENTAL
Intervention: MenC/MenC challenge
Number of subjects: 0
Study 17368663 — intervention group
Group type: EXPERIMENTAL
Intervention: Pnc9-MenC/MnA+C challenge
Number of subjects: 0
Study 17368663 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 0
Study 17368663 — intervention group
Group type: EXPERIMENTAL
Intervention: MenC challenged groups
Number of subjects: 0
Study 16298658 — intervention group
Group type: EXPERIMENTAL
Intervention: Daclizumab 1 mg/kg/dose every 14 days for 5 doses (Group I, n = 107)
Number of subjects: 298
Study 16298658 — intervention group
Group type: EXPERIMENTAL
Intervention: Daclizumab 2 mg/kg/dose every 14 days for 2 doses (Group II, n = 113)
Number of subjects: 298
Study 16298658 — intervention group
Group type: COMPARATOR
Intervention: No antibody induction (Group III, n = 78)
Number of subjects: 298
Study 16298658 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups received tacrolimus (TAC), mycophenolate mofetil (MMF), and steroids
Number of subjects: 298
Study 12042688 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise rehabilitation (3 times per week for 6 months, then 2 times per week for 12 months)
Number of subjects: 31
Study 12042688 — intervention group
Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 31
Study 10392674 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic epidural anesthesia (TEA)
Number of subjects: 28
Study 10392674 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia (GA)
Number of subjects: 28
Study 10392674 — intervention group
Group type: EXPERIMENTAL
Intervention: TEA
Number of subjects: 28
Study 10392674 — intervention group
Group type: COMPARATOR
Intervention: TEA and GA
Number of subjects: 28
Study 7767531 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% lidocaine (5 cc)
Number of subjects: 0
Study 7767531 — intervention group
Group type: COMPARATOR
Intervention: Saline (5 cc)
Number of subjects: 0
Study 2272043 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.0 g/m2 AraC
Number of subjects: 65
Study 2272043 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 g/m2 AraC
Number of subjects: 65
Study 80633 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,25-dihydroxycholecalciferol (1,25[OH]2D3)
Number of subjects: 18
Study 80633 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D3
Number of subjects: 18
Study 30980389 — intervention group
Group type: EXPERIMENTAL
Intervention: Incredible Years® Teacher Classroom Management (TCM) programme delivered in six whole-day workshops from October to April.
Number of subjects: 80
Study 30980389 — intervention group
Group type: COMPARATOR
Intervention: Control group (teachers who did not attend the TCM course).
Number of subjects: 80
Study 31400337 — intervention group
Group type: EXPERIMENTAL
Intervention: Vasopressin infusion for 24 hours after cardiopulmonary bypass
Number of subjects: 20
Study 31400337 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 28731509 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring (CGM)
Number of subjects: 23
Study 26317772 — intervention group
Group type: EXPERIMENTAL
Intervention: Insect consumption (entomophagy)
Number of subjects: 1059
Study 26317772 — intervention group
Group type: EXPERIMENTAL
Intervention: Insect vendors
Number of subjects: 1059
Study 22941862 — intervention group
Group type: COMPARATOR
Intervention: Control arm of the RCT (uncircumcised men)
Number of subjects: 966
Study 21595902 — intervention group
Group type: EXPERIMENTAL
Intervention: Community mobilisation through women's groups and health management committee strengthening
Number of subjects: 43
Study 21595902 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 43
Study 21595902 — intervention group
Group type: EXPERIMENTAL
Intervention: Community mobilisation and health management committee strengthening
Number of subjects: 43
Study 19103732 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose epirubicin with cyclophosphamide (HEC)
Number of subjects: 777